Insulin receptor

Assets acting on this target.

Class
Insulin
Notes
mechanism wave 2026-08-24 (DeepSeek draft; registry text of NCT05441631 names the target); source: https://clinicaltrials.gov/study/NCT05441631

By indication

Related mechanisms

Insulin receptor drugs compared

9 drugs, stage by indication
9 drugs acting on Insulin receptor: developer, modality, furthest stage and stage in each indication. Furthest stage first.
DrugDeveloperModalityFurthest stageStage by indication
insulin aspartNovoLogNovo NordiskpeptideApprovedApproved in Type 1 Diabetes; Approved in Type 2 Diabetes
Insulin aspart (Fiasp)FiaspNovo NordiskpeptideApprovedApproved in Type 1 Diabetes; Approved in Type 2 Diabetes
insulin glulisineApidraSanofipeptideApprovedApproved in Type 1 Diabetes; Approved in Type 2 Diabetes
Insulin LisproHumalogEli LillypeptideApprovedApproved in Type 1 Diabetes; Approved in Type 2 Diabetes
Insulin lispro (Lyumjev)LyumjevEli LillypeptideApprovedApproved in Type 1 Diabetes; Approved in Type 2 Diabetes
insulin NPHHumulin NEli LillypeptideApprovedApproved in Type 1 Diabetes; Approved in Type 2 Diabetes
SAR341402SanofipeptideApprovedApproved in Type 2 Diabetes
THDB0206Adocia, Tonghua Dongbao PharmaceuticalpeptidePhase 3Phase 3 in Type 2 Diabetes
Insulin aspart (AT278)Arecor LimitedpeptidePhase 1Phase 1 in Type 2 Diabetes

← all mechanisms